Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational ICU Trial in Critical Ill COVID-19 Patients (POINT-C) Cardiovascular Risk and the Effects on Myocardial Events in Critical Ill COVID-19 Patients

NCT04349982 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04349982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational ICU Trial in Critical Ill COVID-19 Patients (POINT-C) Cardiovascular Risk and the Effects on Myocardial Events in Critical Ill COVID-19 Patients
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
April 8, 2020
Completion date
March 31, 2022
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

course illness, covid19, critical illness, risk factor, cardiovascular